Duplicate publication uprooted from plant journal

AJPS2015012714522401The American Journal of Plant Sciences has retracted a duplicate publication — and is considerately describing what happened in a checklist that accompanies the retraction note.

The checklist is similar to one that friend of Retraction Watch Hervé Maisonneuve has proposed to the Committee on Publication Ethics.

The retracted paper shares one author with the paper that it duplicated from: Irfan Talib, whose affiliation is listed on the retracted paper as the University of Agriculture in Pakistan.

Here are the relevant fields on the checklist for “Study of Genetic Diversity in Germplasm of Upland Cotton (Gossypium hirsutum L.) in Pakistan” (a PDF on this page includes the checklist and the original paper):

Continue reading Duplicate publication uprooted from plant journal

Retracted anesthesia study “was not conducted in reality”

coverWe’ve come across a new way to say the data in a paper are not reliable:

It has been found that the study represented in the article was not conducted in reality.

That’s from the retraction note for a paper that Anesthesia Essays and Researches has retracted for data falsification. The rest of the retraction note for “Intrathecal dextmedetomidine to reduce shoulder tip pain in laparoscopic cholecystectomies under spinal anesthesia” explains:

Continue reading Retracted anesthesia study “was not conducted in reality”

Sperm paper impaired by “corporate company” analysis

2.coverWithout a certain protein, mouse sperm have motility disorders. That’s the conclusion of a paper that has itself been stopped — by errors in the data analysis, carried out by a third-party company.

The retraction note pins the analysis, which led to faulty data, on a “corporate company.” Aside from the companies that sell the kits used for substrates, assays, and detection, there’s only one company mentioned in the paper:

Generation of the mouse model was performed by the Cyagen Company (Guangzhou, China)

However, a representative of Cyagen says it does not offer the type of analysis described by the retraction note.

Here’s the full retraction note for the 2015 paper in Biology of Reproduction (which is paywalled — tsk, tsk):
Continue reading Sperm paper impaired by “corporate company” analysis

Mistaken plagiarism? Journal retracts education paper that inadvertently included others’ work

An education journal is pulling a 2014 paper about how US funding partnerships in Africa could alleviate local poverty, after the author admitted to mistakenly lifting sentences from work presented at a 2012 conference.

Author Christopher S. Collins at Azusa Pacific University took full responsibility for the plagiarism, and told us he suggested the journal retract the paper — but also proposed alternatives, such as adding the plagiarized author as a co-author, or publishing “an error sheet” that cites the material in the sentences in question.

If it’s hard to imagine how someone could plagiarize another researcher’s work by mistake, Collins explained what happened in a 900-word statement, in which he also told us how he is moving forward professionally and personally.

Here’s how some plagiarized sentences ended up in “Can funding for university partnerships between Africa and the US contribute to social development and poverty reduction?” in Higher Education, according to Collins:

Continue reading Mistaken plagiarism? Journal retracts education paper that inadvertently included others’ work

Fake email address — for author, not reviewer — fells another paper

Screen Shot 2016-02-22 at 10.19.43 AMWe’ve seen many cases of researchers creating fake email addresses to impersonate reviewers that usher their paper to publication.

But in the latest fake email incident, a journal is retracting a paper on liver cancer after the first author created a phony address for the last and corresponding author. Both are researchers at Zhengzhou University in China.

This isn’t the first time that an author has worked around the corresponding author: there’s a case from a few years ago in which the corresponding author didn’t know that the paper was being published at all. Recently, we also wrote about a doctor who was suspended in the UK after submitting papers without her co-authors’ knowledge, including creating a fake email for one of them.

This latest paper had another problem, too: plagiarism. Here’s the retraction note for “The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer,” published in OncoTargets and Therapy:

Continue reading Fake email address — for author, not reviewer — fells another paper

“Evidence-based medicine has been hijacked:” A confession from John Ioannidis

ioannidis
John Ioannidis

John Ioannidis is perhaps best known for a 2005 paper “Why Most Published Research Findings Are False.” One of the most highly cited researchers in the world, Ioannidis, a professor at Stanford, has built a career in the field of meta-research. Earlier this month, he published a heartfelt and provocative essay in the the Journal of Clinical Epidemiology titled “Evidence-Based Medicine Has Been Hijacked: A Report to David Sackett.” In it, he carries on a conversation begun in 2004 with Sackett, who died last May and was widely considered the father of evidence-based medicine. We asked Ioannidis to expand on his comments in the essay, including why he believes he is a “failure.”

Retraction Watch: You write that as evidence-based medicine “became more influential, it was also hijacked to serve agendas different from what it originally aimed for.” Can you elaborate? Continue reading “Evidence-based medicine has been hijacked:” A confession from John Ioannidis

Authorship, funding misstatements force retraction of satellite study

rslRemote Sensing Letters has retracted a 2015 paper by a pair of researchers in China because the duo was in fact a solo, and the manuscript lied about its funding source.

The article, “A novel method of feature extraction and fusion and its application in satellite images classification,” purportedly was written by Da Lin and Xin Xu, of Wuhan University. But as the retraction notice makes clear, that wasn’t the case: Continue reading Authorship, funding misstatements force retraction of satellite study

Shigeaki Kato up to 38 retractions

Shigeaki Kato
Shigeaki Kato

Our retraction notice count for Shigeaki Kato, number seven on our leaderboard, has grown to 38.

The former University of Tokyo endocrinologist recently earned another retraction, for a paper in Archives of Biochemistry and Biophysics that contained image manipulation. As we’ve noted before, Kato resigned from the university in 2012 as it investigated his work for misconduct; in 2013 a Japanese newspaper reported that the investigation had found 43 papers from his lab contained “likely altered or forged materials.”

In addition to the new retraction, we’ve dug up four others for Kato from the past few years, plus one correction. Two of the retraction notices mention an investigation at the University of Tokyo.

First, the retraction note for “Multiple co-activator complexes support ligand-induced transactivation function of VDR,” published in December:

Continue reading Shigeaki Kato up to 38 retractions

NEJM corrects 3 papers after prominent cancer scientist left off credit for breakthrough

Screen Shot 2016-03-15 at 12.04.43 PMThe New England Journal of Medicine has corrected three highly cited papers to credit researchers who played a role in the work.

The papers describe a treatment in which engineered T cells fight leukemia, originally hailed as a “major advance” in the New York Times. Since the first paper appeared in 2011, co-author Carl June at the University of Pennsylvania has received more than $7 million in grants from the National Institutes of Health, according to MIT Technology Review. But according to a newly published correction, the three NEJM papers failed to note in the acknowledgement section that an important component of the experiments was supplied by researchers at St. Jude Children’s Research Hospital.

The correction, made 11 months after a request from co-author and Penn researcher David Porter, explains the contribution of the St Jude’s researchers:

Continue reading NEJM corrects 3 papers after prominent cancer scientist left off credit for breakthrough

Want to help us report? Here’s a sneak peek at what we’re working on

RWThere are hundreds of retractions per year, and a constant stream of new developments in publishing and fraud — all of which keeps our small staff very busy.

As a result, we can’t immediately post on every new retraction that we or our readers discover. So we’ve created a new page to show you some of what’s on our current to-do list, to give you a “sneak peek” at what’s to come. If you have any tips for us about a retraction, expression of concern, or correction you see on our “help us” page — or know of any other retractions by the same authors — please let us know in a comment.

For example, here are some of the retractions on that page now: Continue reading Want to help us report? Here’s a sneak peek at what we’re working on